Product Information
GLIPIZIDE-METFORMIN 2.5-500 MG is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.2334 per EA under NDC 00093745601. Its NADAC has been published 657 times since Nov 28, 2013.
Strength
2.5; 500 mg/1; mg/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00093745601
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
GLIPIZIDE; METFORMIN HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA077270On Market Since
10/28/2005
Pharmacological Classes
Price Statistics
The NADAC for GLIPIZIDE-METFORMIN 2.5-500 MG has been published 657 times since Nov 28, 2013, and over the history we have for it it has declined 49.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2334 per EA |
|---|---|
| All-time high | $0.6303 (Aug 10, 2016) |
| All-time low | $0.1992 (Jun 23, 2021) |
| 52-week high | $0.3088 |
| 52-week low | $0.2223 |
| Median price | $0.2994 |
| Average price | $0.3513 |
| Largest weekly change | +43.5% (Sep 23, 2020) |
| Weeks tracked | 657 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of GLIPIZIDE-METFORMIN 2.5-500 MG?
The current National Average Drug Acquisition Cost (NADAC) for GLIPIZIDE-METFORMIN 2.5-500 MG, manufactured by Teva Pharmaceuticals USA Inc., is $0.2334 per EA (NDC 00093745601), effective Jun 24, 2026.
How has the price of GLIPIZIDE-METFORMIN 2.5-500 MG changed over time?
Over the history we have for it, the NADAC for GLIPIZIDE-METFORMIN 2.5-500 MG has declined 49.0%. It has been tracked across 657 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for GLIPIZIDE-METFORMIN 2.5-500 MG?
Since Nov 28, 2013, the NADAC for GLIPIZIDE-METFORMIN 2.5-500 MG has ranged from a low of $0.1992 (Jun 23, 2021) to a high of $0.6303 (Aug 10, 2016), with a median of $0.2994 per EA.
Are there cheaper alternatives to GLIPIZIDE-METFORMIN 2.5-500 MG?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as GLIPIZIDE-METFORMIN 2.5-500 MG, but none are currently priced below it.
Who manufactures GLIPIZIDE-METFORMIN 2.5-500 MG?
GLIPIZIDE-METFORMIN 2.5-500 MG (NDC 00093745601) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification